Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback